Craig Ostroff

Conference Coverage

No Evidence That BCMA Expression Is Completely Lost Following Belamaf Treatment in Patients With RRMM

12/10/2022

In a presentation at the 64th Annual ASH Meeting and Exposition, Daniel E Lowther, PhD, and colleagues discuss their study to determine if immune impairment and complete target loss were seen in patients with relapsed/refractory multiple...

In a presentation at the 64th...

12/10/2022

Journal of Clinical Pathways

Conference Coverage

Quality of Care and Research Initiatives in the Enhancing Oncology Model

10/15/2022

Katie Herman ;

Craig Ostroff ;

Lee A. Fleisher, MD, CMS Chief Medical Officer, Director, Center for Clinical Standards and Quality, presented data at the 2022 Oncology Clinical Pathways Congress regarding the Oncology Care Model as well as the development plan for the...

Lee A. Fleisher, MD, CMS Chief...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Just in Time Clinical Trials: A Solution for Both Academia and Community Oncology

10/18/2022

Craig Ostroff ;

At the 2022 Oncology Clinical Pathways Congress, Dr Ira Klein discussed the need to improve access and reach typically underrepresented populations in order to make clinical trials and cancer treatment studies more representative of the...

At the 2022 Oncology Clinical...

10/18/2022

Journal of Clinical Pathways

Conference Coverage

PRO-Based Symptom Management Shows Links to Improved Clinical Outcomes

09/30/2022

Craig Ostroff ;

Randomized controlled trials at academic medical centers have shown an improvement in clinical outcomes when utilizing patient-reported outcome-based symptom management solutions, according to a presentation at the 2022 ASCO Quality Care...

Randomized controlled trials at...

09/30/2022

Journal of Clinical Pathways

Conference Coverage

Pharmacy Benefits With Rising Costs of Cancer Care

10/15/2022

Craig Ostroff ;

Sibel Blau, MD, Medical Director at Northwest Medical Specialties, PLLC, and James Gelfand, President of the ERISA Industry Committee, presented at the 2022 Oncology Clinical Pathways Congress about pharmacy benefits in value-based pathways.

Sibel Blau, MD, Medical Director...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Precision Medicine and AI in Oncology Patient Care

10/16/2022

Katie Herman ;

Craig Ostroff ;

Tushar Pandey, CEO, SimBioSys, Inc, in his 2022 Oncology Clinical Pathways Congress presented on the value artificial intelligence brings to oncology patient care, and the need to move to guided intelligence.

Tushar Pandey, CEO, SimBioSys,...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Pathway Compliance Linked to First-Line Treatment Regimen

09/30/2022

Craig Ostroff ;

Pathway compliance was observed in almost two-thirds of cases among patients with metastatic disease who were treated in the first-line setting, according to a presentation at the 2022 ASCO Quality Care Symposium. Due to increasing health...

Pathway compliance was observed...

09/30/2022

Journal of Clinical Pathways

Conference Coverage

System Challenges in Oncology Care—A Patient Perspective

10/15/2022

Craig Ostroff ;

Kellee Franklin, PhD, Chief Innovation Officer at Mindful Innovation Labs, strategic innovation consultant, shared her journey of her cancer diagnosis in 2013 and the challenges she faced with the system.

Kellee Franklin, PhD, Chief...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

Optimal Utilization of Telehealth to Enhance Patient Care and Clinical Trial Participation

10/18/2022

Katie Herman ;

Craig Ostroff ;

Matthew A Lunning, DO, FACP, Associate Professor, Fred & Pamela Buffett Cancer Center, Associate Vice-Chair of Research Department of Medicine, Assistant Vice Chancellor of Clinical Research, University of Nebraska Medical Center, Omaha,...

Matthew A Lunning, DO, FACP,...

10/18/2022

Journal of Clinical Pathways

Conference Coverage

Evaluating Cost Savings of Collaborative Cancer-Patient Navigation Program Compared to Embedded Programs

09/30/2022

Craig Ostroff ;

Cancer-patient navigation programs tend to reduce total costs of care and improve outcomes. This study, presented at the 2022 ASCO Quality Care Symposium, explored whether an independent cancer-patient navigation program in collaboration with...

Cancer-patient navigation...

09/30/2022

Journal of Clinical Pathways